How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | GHGuardant Health, Inc. | CVSCVS HEALTH Corp | CICigna Group | DGXQUEST DIAGNOSTICS INC | Median of the restexcluding GH |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $162.94▼ 3.72 (2.23%) | $94.48▲ 1.03 (1.10%) | $304.37▼ 2.23 (0.73%) | $243.28▲ 4.35 (1.82%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 6.0/10 | 4.7/10 | 6.0/10 | 8.0/10 | 6.0/10 |
| Market value | $21.29B | $120.08B | $80.19B | $27.00B | |
| Revenue | $982.0M | $402.07B | $274.90B | $11.04B | |
| Profit | -$416.3M | $1.77B | $5.96B | $992.0M | |
| Revenue growthChange in sales versus the prior year. | 32.9% | 7.8% | 11.2% | 11.8% | 11.2% |
| Gross marginShare of sales left after the direct cost of producing them. | 64.5% | 45.0% | 21.8% | 33.2% | 33.2% |
| Operating marginShare of sales left after running the business, before interest and tax. | -44.5% | 1.2% | 3.3% | 14.1% | 3.3% |
| Profit marginProfit kept from each dollar of sales. | -42.4% | 0.4% | 2.2% | 9.0% | 2.2% |
| Free cash flow marginCash left after capital spending, as a share of sales. | -23.7% | 1.9% | — | 12.3% | 7.1% |
| Return on equityProfit against the owners' stake in the company. | 419.2% | 2.4% | 14.3% | 13.8% | 13.8% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | -33.7% | 3.0% | 10.8% | 9.4% | 9.4% |
| P/E ratioPrice paid per dollar of annual profit. | — | 67.92x | 13.46x | 27.22x | 27.22x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | — | 18.58x | 8.68x | 15.17x | 15.17x |
| Price to book | -214.34x | 1.60x | 1.92x | 3.77x | 1.92x |
| Debt to equityTotal liabilities compared with owners' stake. | -21.28x | 2.37x | 2.78x | 1.26x | 2.37x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 5/9 | 8/9 | 7/9 | 8/9 | 8.0 |
| Bankruptcy riskAltman Z-Score zone. | distress | distress | n/a for banks | safe |
How GH compares with the others
- GH's operating margin of -44.5% is lower than the median of the other companies selected (3.3%).
- Its revenue grew faster than the median of the other companies selected: 32.9% against 11.2%.
- It has no P/E to set against theirs, because it did not make a profit.
- Its liabilities are lower relative to equity than the median of the other companies selected: -21.3x against 2.4x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.